There is information missing from the Funding section. The correct funding information is as follows: This work was funded by Canada Research Chair funds to LS and Leukemia and Lymphoma Society of Canada Grant (#317359) to LS, the Orsino Chair in Leukemia Research, Marvin and Linda Barnett leukemia Research Fund, Brian Steck Leukemia Research Fund to MDM and an Innovation Grant of the Canadian Cancer Society, and Brain Canada with the financial support of Health Canada (# 705166) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The publisher apologizes for the error.
- 1. Dzneladze I, Woolley JF, Rossell C, Han Y, Rashid A, Jain M, et al. (2018) SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML. PLoS ONE 13(2): e0191510. https://doi.org/10.1371/journal.pone.0191510 pmid:29415082
Citation: The PLOS ONE Staff (2018) Correction: SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML. PLoS ONE 13(3): e0195417. https://doi.org/10.1371/journal.pone.0195417
Published: March 29, 2018
Copyright: © 2018 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.